Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Fatal attraction: chemokines and type 1 diabetes
Mark A. Atkinson, S. Brian Wilson
Mark A. Atkinson, S. Brian Wilson
Published December 1, 2002
Citation Information: J Clin Invest. 2002;110(11):1611-1613. https://doi.org/10.1172/JCI17311.
View: Text | PDF
Commentary

Fatal attraction: chemokines and type 1 diabetes

  • Text
  • PDF
Abstract

Commentary

Authors

Mark A. Atkinson, S. Brian Wilson

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
The influence of CCR4 in islet inflammation. Adoptive transfer studies p...
The influence of CCR4 in islet inflammation. Adoptive transfer studies performed by Kim et al. (2) suggest that CCR4-expressing T cells obtained from 16- to 18-week-old diabetic NOD mice confer a higher capacity for imparting pancreatic inflammation (i.e., insulitis) in NOD-scid recipients than do CCR4-negative cells. Indeed, the figure clearly demonstrates a marked degree of infiltration, and disruption of islet architecture was associated with transfer of CCR4-positive cells. It is key to note that this figure should be considered as representative since the quantitative data for insulitis reported in the study were not as striking as those qualitatively demonstrated in this figure in terms of the differences in inflammatory capacity afforded by the two populations of cells. However, this work does support a role of CCR4 in the homing of inflammatory cells to the pancreatic islet. This study provides a conceptual framework for the design of therapeutics aimed at interrupting the formation of insulitis and the eventual development of type 1 diabetes.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts